Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention : COX-2 inhibition in gastroenterology and rheumatology: current challenges and perspectives for the futureBOURSI, Ben; ARBER, Nadir.Current pharmaceutical design. 2007, Vol 13, Num 22, pp 2274-2282, issn 1381-6128, 9 p.Article

Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention : PointARBER, Nadir; JANKOWSKI, Janusz; HUNT, Richard et al.Cancer epidemiology, biomarkers & prevention. 2008, Vol 17, Num 8, pp 1852-1861, issn 1055-9965, 10 p.Article

The role of nutrition and chemoprevention in colorectal cancer: from observations to expectationsVAISMAN, Nachum; ARBER, Nadir.Baillière's best practice & research. Clinical gastroenterology. 2002, Vol 16, Num 2, pp 201-217, issn 1521-6918Article

Cyclooxygenase-2 inhibition prevents colorectal cancer : From the bench to the bed sideSAMOHA, Smadar; ARBER, Nadir.Oncology. 2005, Vol 69, pp 33-37, issn 0030-2414, 5 p., SUP1Conference Paper

Gene Expression Analysis Proposes Alternative Pathways for the Mechanism by Which Celecoxib Selectively Inhibits the Growth of Transformed but not Normal EnterocytesSAGIV, Eyal; ROZOVSKI, Uri; KAZANOV, Diana et al.Clinical cancer research. 2007, Vol 13, Num 22, pp 6807-6815, issn 1078-0432, 9 p., 1Article

Suppression of gastric cancer cell growth by targeting the β-catenin/T-cell factor pathwayDVORY-SOBOL, Hadas; SAGIV, Eyal; LIBERMAN, Eliezer et al.Cancer. 2007, Vol 109, Num 2, pp 188-197, issn 0008-543X, 10 p.Article

The APC E1317Q and I1307K polymorphisms in non-colorectal cancersLIBERMAN, Eliezer; KRAUS, Sarah; SAGIV, Eyal et al.Biomedicine & pharmacotherapy. 2007, Vol 61, Num 9, pp 566-569, issn 0753-3322, 4 p.Conference Paper

Down-regulation of PGE₂ by physiologic levels of celecoxib is not sufficient to induce apoptosis or inhibit cell proliferation in human colon carcinoma cell linesLEV-ARI, Shahar; KAZANOV, Dina; LIBERMAN, Eliezer et al.Digestive diseases and sciences. 2007, Vol 52, Num 4, pp 1128-1133, issn 0163-2116, 6 p.Article

Sensitive digital quantification of DNA methylation in clinical samplesMENG LI; CHEN, Wei-Dong; DURKEE, Kris et al.Nature biotechnology (Print). 2009, Vol 27, Num 9, pp 858-863, issn 1087-0156, 6 p.Article

Gene therapy approach in prostate cancer cells using an active Wnt signalGILADI, Nis; DVORY-SOBOL, Hadas; SAGIV, Eyal et al.Biomedicine & pharmacotherapy. 2007, Vol 61, Num 9, pp 527-530, issn 0753-3322, 4 p.Conference Paper

Celecoxib but not rofecoxib inhibits the growth of transformed cells in vitroKAZANOV, Diana; DVORY-SOBOL, Hadas; PICK, Marjorie et al.Clinical cancer research. 2004, Vol 10, Num 1, pp 267-271, issn 1078-0432, 5 p., 1Article

Appendectomy is more frequent but not a risk factor in Crohn's disease while being protective in ulcerative colitis : A comparison of surgical procedures in inflammatory bowel diseaseREIF, Shimon; LAVY, Alexandra; FICH, Alexander et al.The American journal of gastroenterology. 2001, Vol 96, Num 3, pp 829-832, issn 0002-9270Article

Five-Year Analysis of the Prevention of Colorectal Sporadic Adenomatous Polyps TrialARBER, Nadir; SPICAK, Julius; LEVIN, Bernard et al.The American journal of gastroenterology. 2011, Vol 106, Num 6, pp 1135-1146, issn 0002-9270, 12 p.Article

Celecoxib leads to G₂/M arrest by induction of p21 and down-regulation of cyclin B1 expression in a p53-independent mannerDVORY-SOBOL, Hadas; COHEN-NOYMAN, Efrat; KAZANOV, Diana et al.European journal of cancer (1990). 2006, Vol 42, Num 3, pp 422-426, issn 0959-8049, 5 p.Article

Oncogenic transformation of normal enterocytes by overexpression of cyclin D1KAZANOV, Diana; SHAPIRA, Itzhak; PICK, Marjorie et al.Digestive diseases and sciences. 2003, Vol 48, Num 7, pp 1251-1261, issn 0163-2116, 11 p.Article

Increased erythrocyte adhesiveness/aggregation in the peripheral venous blood of patients with ischaemic heart disease and an eventful courseBERLINER, Shlomo; ROTSTEIN, Rivka; ZELTSER, David et al.Acta cardiologica. 2001, Vol 56, Num 2, pp 121-126, issn 0001-5385, 6 p.Article

CD24 knockout prevents colorectal cancer in chemically induced colon carcinogenesis and in APC^Min/CD24 double knockout transgenic miceNAUMOV, Inna; ZILBERBERG, Alona; SHAPIRA, Shiran et al.International journal of cancer (Print). 2014, Vol 135, Num 5, pp 1048-1059, issn 0020-7136, 12 p.Article

Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials : The Cross Trial Safety AnalysisSOLOMON, Scott D; WITTES, Janet; PATER, Joseph L et al.Circulation (New York, N.Y.). 2008, Vol 117, Num 16, pp 2104-2113, issn 0009-7322, 10 p.Article

Initial experience of videocapsule endoscopy for diagnosing small-bowel tumors in patients with GI polyposis syndromesBARKAY, Olga; MOSHKOWITZ, Menachem; FIREMAN, Zvi et al.Gastrointestinal endoscopy. 2005, Vol 62, Num 3, pp 448-452, issn 0016-5107, 5 p.Article

Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin DHOLT, Peter R; ARBER, Nadir; HALMOS, Balazs et al.Cancer epidemiology, biomarkers & prevention. 2002, Vol 11, Num 1, pp 113-119, issn 1055-9965Article

The inflammation meter : Novel technology to detect the presence of infection/inflammation in patients without leukocytosis but with increased leukocyte adhesiveness/aggregationMAHARSHAK, Nitsan; KASSIRER, Michael; ZELTSER, David et al.Acta haematologica. 2000, Vol 104, Num 1, pp 16-21, issn 0001-5792Article

Celecoxib for the prevention of colorectal adenomatous polypsARBER, Nadir; EAGLE, Craig J; ROSENSTEIN, Rebecca B et al.The New England journal of medicine. 2006, Vol 355, Num 9, pp 885-895, issn 0028-4793, 11 p.Article

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomasSOLOMON, Scott D; PFEFFER, Marc A; BERTAGNOLLI, Monica M et al.Circulation (New York, N.Y.). 2006, Vol 114, Num 10, pp 1028-1035, issn 0009-7322, 8 p.Article

Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cellsLEV-ARI, Shahar; STRIER, Ludmila; KAZANOV, Diana et al.Clinical cancer research. 2005, Vol 11, Num 18, pp 6738-6744, issn 1078-0432, 7 p.Article

The I1307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi JewsSTRUL, Hana; BARENBOIM, Erez; KNAANI, Yehudit et al.Cancer epidemiology, biomarkers & prevention. 2003, Vol 12, Num 10, pp 1012-1015, issn 1055-9965, 4 p.Article